Structure-Based Consensus Scoring Scheme for Selecting Class A Aminergic GPCR Fragments

Journal of Chemical Information and Modeling

Volumn 56, Issue 2, 2016, Pages 412-422

  Kelemen, Ádám A ^a   Kiss, Róbert ^a   Ferenczy, György G ^a   Kovács, László ^b   Flachner, Beáta ^a,c   Lorincz, Zsolt ^a,c   Keseru, György M ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b Infarmatik Inc ^*  (United States)

^c TargetEx   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; LIBRARIES; LIGANDS; PROTEINS;

CELL-BASED ASSAYS; CENTRAL NERVOUS SYSTEMS; COMPOUND COLLECTIONS; DOCKING CALCULATIONS; G PROTEIN COUPLED RECEPTORS; PROTEIN ENSEMBLES; SEROTONIN RECEPTORS; VIRTUAL SCREENING;

DIGITAL LIBRARIES;

AMINE; G PROTEIN COUPLED RECEPTOR;

ANIMAL; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CHO CELL LINE; CRICETULUS; HAMSTER; MOLECULAR DOCKING;

AMINES; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; MODELS, CHEMICAL; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84961177291     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/acs.jcim.5b00598     Document Type: Article

References (49)

1. Kelemen, á.A.; Ferenczy, G. G.; Keseru, G. M. A desirability function-based scoring scheme for selecting fragment-like class A aminergic GPCR ligands J. Comput.-Aided Mol. Des. 2015, 29, 59-66 10.1007/s10822-014-9804-5
2. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: a G protein-coupled receptor Science 2000, 289, 739-45 10.1126/science.289.5480.739
3. Topiol, S.; Sabio, M. X-ray structure breakthroughs in the GPCR transmembrane region Biochem. Pharmacol. 2009, 78, 11-20 10.1016/j.bcp.2009.02.012
4. Bohacek, R. S.; McMartin, C.; Guida, W. C. The art and practice of structure-based drug design: a molecular modeling perspective Med. Res. Rev. 1996, 16, 3-50 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.3.CO;2-D
5. Totrov, M.; Abagyan, R. Flexible ligand docking to multiple receptor conformations: a practical alternative Curr. Opin. Struct. Biol. 2008, 18, 178-184 10.1016/j.sbi.2008.01.004
6. Huang, S. Y.; Zou, X. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking Proteins: Struct., Funct., Genet. 2007, 66, 399-421 10.1002/prot.21214
7. Spyrakis, F.; Cavasotto, C. N. Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description Arch. Biochem. Biophys. 2015, 583, 105-19 10.1016/j.abb.2015.08.002
8. Sinko, W.; Lindert, S.; McCammon, J. A. Accounting for receptor flexibility and enhanced sampling methods in computer-aided drug design Chem. Biol. Drug Des. 2013, 81, 41-49 10.1111/cbdd.12051
9. Andrews, S. P.; Brown, G. A.; Christopher, J. A. Structure-Based and Fragment-Based GPCR Drug Discovery ChemMedChem 2014, 9, 256-275 10.1002/cmdc.201300382
10. ChEMBL GPCR SARfari Home Page. https://www.ebi.ac.uk/chembl/sarfari/gpcrsarfari (accessed February 1, 2014).
11. PubChem home page. https://pubchem.ncbi.nlm.nih.gov/ (accessed March 14, 2014).
12. Haga, K.; Kruse, A. C.; Asada, H.; Yurugi-Kobayashi, T.; Shiroishi, M.; Zhang, C.; Weis, W. I.; Okada, T.; Kobilka, B. K.; Haga, T.; Kobayashi, T. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist Nature 2012, 482, 547-551 10.1038/nature10753
13. Kruse, A.C.; Ring, A. M.; Manglik, A.; Hu, J.; Hu, K.; Eitel, K.; Hubner, H.; Pardon, E.; Valant, C.; Sexton; Christopoulos, A.; Felder, C. C.; Gmeiner, P.; Steyaert, J.; Weis, W. I.; Garcia, K. C.; Wess, J.; Kobilka, B. K. Activation and allosteric modulation of a muscarinic acetylcholine receptor Nature 2013, 504, 101-106 10.1038/nature12735
14. Cherezov, V.; Rosenbaum, D. M.; Hanson, M. A.; Rasmussen, S. G. F.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Kuhn, P.; Weis, W. I.; Kobilka, B.K.; Stevens, R. C. High-resolution crystal structure of an engineered human b2-adrenergic G protein-coupled receptor Science 2007, 318, 1258-1265 10.1126/science.1150577
15. Hanson, M. A.; Cherezov, V.; Griffith, M. T.; Roth, C. B.; Jaakola, V. P.; Chien, E. Y.; Velasquez, J.; Kuhn, P.; Stevens, R.C. A specific cholesterol binding site is established by the 2.8 A° structure of the human b2-adrenergic receptor Structure 2008, 16, 897-905 10.1016/j.str.2008.05.001
16. Wacker, D.; Fenalti, G.; Brown, M. A.; Katritch, V.; Abagyan, R.; Cherezov, V.; Stevens, R. C. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography J. Am. Chem. Soc. 2010, 132, 11443-11445 10.1021/ja105108q
17. Rosenbaum, D. M.; Zhang, C.; Lyons, J. A.; Holl, R.; Aragao, D.; Arlow, D. H.; Rasmussen, S. G. F.; Choi, H. J.; Devree, B. T.; Sunahara, R. K.; Chae, P. S.; Gellman, S. H.; Dror, R. O.; Shaw, D. E.; Weis, W. I.; Caffrey, M.; Gmeiner, P.; Kobilka, B. K. Structure and function of an irreversible agonist-β(2) adrenoceptor complex Nature 2011, 469, 236-240 10.1038/nature09665
18. Zou, Y.; Weis, W. I.; Kobilka, B. K. N-terminal T4 lysozyme fusion facilitates crystallization of a G protein coupled receptor PLoS One 2012, 7, e46039-e46039 10.1371/journal.pone.0046039
19. Ring, A. M.; Manglik, A.; Kruse, A. C.; Enos, M. D.; Weis, W. I.; Garcia, K. C.; Kobilka, B. K. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody Nature 2013, 502, 575-579 10.1038/nature12572
20. Rasmussen, S. G. F.; Choi, H. J.; Fung, J. J.; Pardon, E.; Casarosa, P.; Chae, P. S.; Devree, B. T.; Rosenbaum, D. M.; Thian, F. S.; Kobilka, T. S.; Schnapp, A.; Konetzki, I.; Sunahara, R. K.; Gellman, S. H.; Pautsch, A.; Steyaert, J.; Weis, W. I.; Kobilka, B. K. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor Nature 2011, 469, 175-180 10.1038/nature09648
21. Rasmussen, S. G.; Choi, H. J.; Rosenbaum, D. M.; Kobilka, T. S.; Thian, F. S.; Edwards, P. C.; Burghammer, M.; Ratnala, V. R.; Sanishvili, R.; Fischetti, R. F.; Schertler, G. F.; Weis, W. I.; Kobilka, B. K. Crystal structure of the human b2 adrenergic G-protein-coupled receptor Nature 2007, 450, 383-388 10.1038/nature06325
22. Bokoch, M. P.; Zou, Y.; Rasmussen, S. G.; Liu, C. W.; Nygaard, R.; Rosenbaum, D. M.; Fung, J. J.; Choi, H. J.; Thian, F. S.; Kobilka, T. S.; Puglisi, J. D.; Weis, W. I.; Pardo, L.; Prosser, R. S.; Mueller, L.; Kobilka, B. K. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor Nature 2010, 463, 108-112 10.1038/nature08650
23. Weichert, D.; Kruse, A. C.; Manglik, A.; Hiller, C.; Zhang, C.; Hubner, H.; Kobilka, B. K.; Gmeiner, P. Covalent agonists for studying G protein-coupled receptor activation Proc. Natl. Acad. Sci. U. S. A. 2014, 111, 10744-10748 10.1073/pnas.1410415111
24. Wang, C.; Jiang, Y.; Ma, J.; Wu, H.; Wacker, D.; Katritch, V.; Han, G. W.; Liu, W.; Huang, X. P.; Vardy, E.; McCorvy, J. D.; Gao, X.; Zhou, X. E.; Melcher, K.; Zhang, C.; Bai, F.; Yang, H.; Yang, L.; Jiang, H.; Roth, B. L.; Cherezov, V.; Stevens, R. C.; Xu, H. E. Structural Basis for Molecular Recognition at Serotonin Receptors Science 2013, 340, 610-614 10.1126/science.1232807
25. Wacker, D.; Wang, C.; Katritch, V.; Han, G. W.; Huang, X. P.; Vardy, E.; McCorvy, J. D.; Jiang, Y.; Chu, M.; Siu, F. Y.; Liu, W.; Xu, H. E.; Cherezov, V.; Roth, B. L.; Stevens, R. C. Structural features for functional selectivity at serotonin receptors Science 2013, 340, 615-619 10.1126/science.1232808
26. Liu, W.; Wacker, D.; Gati, C.; Han, G. W.; James, D.; Wang, D.; Nelson, G.; Weierstall, U.; Katritch, V.; Barty, A.; Zatsepin, N. A.; Li, D.; Messerschmidt, M.; Boutet, S.; Williams, G. J.; Koglin, J. E.; Seibert, M. M.; Wang, C.; Shah, S. T.; Basu, S.; Fromme, R.; Kupitz, C.; Rendek, K. N.; Grotjohann, I.; Fromme, P.; Kirian, R. A.; Beyerlein, K. R.; White, T. A.; Chapman, H. N.; Caffrey, M.; Spence, J. C.; Stevens, R. C.; Cherezov, V. Serial femtosecond crystallography of G protein-coupled receptors Science 2013, 342, 1521-1524 10.1126/science.1244142
27. Chien, E. Y.; Liu, W.; Zhao, Q.; Katritch, V.; Han, G. W.; Hanson, M. A.; Shi, L.; Newman, A. H.; Javitch, J. A.; Cherezov, V.; Stevens, R. C. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist Science 2010, 330, 1091-1095 10.1126/science.1197410
28. Shimamura, T.; Shiroishi, M.; Weyand, S.; Tsujimoto, H.; Winter, G.; Katritch, V.; Abagyan, R.; Cherezov, V.; Liu, W.; Han, G. W.; Kobayashi, T.; Stevens, R. C.; Iwata, S. Structure of the human histamine H1 receptor complex with doxepin Nature 2011, 475, 65-70 10.1038/nature10236
29. RCSB PDB. www.rcsb.org (accessed March 14, 2014).
30. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. Protein Data Bank Nucleic Acids Research 2000, 28, 235-242 10.1093/nar/28.1.235
31. Protein Preparation, Version X; Schrödinger, LLC: New York, NY, 2011.
32. LigPrep, Version 2.5; Schrödinger, LLC: New York, NY, 2011.
33. Glide, Version 5.7; Schrödinger, LLC: New York, NY, 2011.
34. Clustering of Conformers; Schrödinger, LLC: New York, NY. http://www.schrodinger.com/scriptcenter/ (accessed June 19, 2014).
35. Nissink, J. W. M. Simple Size-Independent Measure of Ligand Efficiency J. Chem. Inf. Model. 2009, 49 (6) 1617-22 10.1021/ci900094m
36. Knime Desktop (Konstanz Information Miner), version 2.9.1; 2014.
37. JChem for Excel, ChemAxon for Knime, ChemAxon fingerprint, version 5.2; Chemaxon: Budapest, Hungary, 2014.
38. ChEMBL home page. ftp://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/ (accessed 2014).
39. Nicholls, A. Confidence limits, error bars and method comparison in molecular modelling. Part 1: The calculation of confidence intervals J. Comput.-Aided Mol. Des. 2014, 28, 887-918 10.1007/s10822-014-9753-z
40. McGann, M.; Nicholls, A.; Enyedy, I. The statistics of virtual screening and lead optimization J. Comput.-Aided Mol. Des. 2015, 29, 923-936 10.1007/s10822-015-9861-4
41. Segall, M. D. Multi-Parameter Optimization: Identifying high quality compounds with a balance of properties Curr. Drug Metab. 2012, 18, 1292-1310 10.2174/138920012799362864
42. Marazziti, D.; Baroni, S.; Borsini, F.; Picchetti, M.; Vatteroni, E.; Falaschi, V.; Catena-Dell'Osso, M. Serotonin Receptors of Type 6 (5-HT6): From Neuroscience to Clinical Pharmacology Curr. Med. Chem. 2013, 20, 371-377 10.2174/092986713804870774
43. 6 Antagonists from Large Commercial Repositories Chem. Biol. Drug Des. 2015, 86, 864-880 10.1111/cbdd.12563
44. Whitty, A. Growing Pains in Academic Drug Discovery Future Med. Chem. 2011, 3, 797-801 10.4155/fmc.11.44
45. Baell, J. B.; Holloway, G. A. New Subsctructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays J. Med. Chem. 2010, 53, 2719-2740 10.1021/jm901137j
46. 6 receptor J. Comput.-Aided Mol. Des. 2015, 29, 1137-1149 10.1007/s10822-015-9883-y
47. Tarcsay, A.; Paragi, G.; Vass, M.; Jójárt, B.; Bogár, F.; Keseru, G. M. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs J. Chem. Inf. Model. 2013, 53, 2990-2999 10.1021/ci400087b
48. 6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease Neurotherapeutics 2008, 5, 458-469 10.1016/j.nurt.2008.05.008
49. Lan, R.; Liu, Q.; Fan, P.; Lin, S.; Fernando, S. R.; McCallion, D.; Pertwee, R.; Makriyannis, A. Structure-Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists J. Med. Chem. 1999, 42, 769-776 10.1021/jm980363y